Dermatological Manifestations in Inflammatory Bowel Diseases

Area of Science:

• Gastroenterology
• Dermatology
• Internal Medicine

Background:

• Inflammatory bowel diseases (IBD) are systemic conditions often presenting with extra-intestinal manifestations.
• Mucocutaneous manifestations are common in IBD patients, posing diagnostic and therapeutic challenges.
• These skin conditions can complicate the overall management and prognosis of IBD.

Purpose of the Study:

• To review and summarize the literature on dermatological manifestations associated with IBD.
• To categorize the various mucocutaneous conditions linked to inflammatory bowel diseases.
• To emphasize the importance of dermatological evaluation in IBD management, particularly with biologic therapies.

Main Methods:

• Comprehensive literature review of relevant studies on IBD and associated mucocutaneous conditions.
• Identification and classification of distinct categories of dermatological manifestations.
• Analysis of the clinical relevance and diagnostic implications of these findings.

Main Results:

• Identified five main categories of mucocutaneous manifestations in IBD: specific IBD-related, associated disorders, reactive conditions, treatment-induced reactions, and those due to nutritional malabsorption.
• Specific examples include aphthous stomatitis, erythema nodosum, psoriasis, pyoderma gangrenosum, and various nutritional deficiency signs.
• Drug-induced cutaneous reactions are particularly significant in patients receiving biologic therapies.

Conclusions:

• Mucocutaneous manifestations are a significant feature of inflammatory bowel diseases, requiring careful dermatological assessment.
• Accurate diagnosis and management of these skin conditions are essential for improving patient outcomes.
• Routine dermatological examination is vital for all IBD patients, especially those undergoing biologic treatment.